What is the role of intravenous (IV) noradrenaline (norepinephrine) in managing hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norepinephrine is the First-Line Vasopressor for Hypotension in Septic Shock

Norepinephrine should be initiated as the first-choice vasopressor to maintain mean arterial pressure ≥65 mmHg when hypotension persists after adequate fluid resuscitation (minimum 30 mL/kg crystalloid bolus). 1

Initial Resuscitation Strategy

Fluid Resuscitation First

  • Administer a minimum 30 mL/kg crystalloid bolus before or concurrent with norepinephrine initiation 1, 2
  • Use crystalloids (normal saline or balanced crystalloids like lactated Ringer's) as first-line fluid 1
  • Avoid hydroxyethyl starch (HES) formulations entirely due to increased mortality (51% vs 43%, p=0.03) and renal injury 1, 2

Exception: Profound Life-Threatening Hypotension

  • In severe hypotension (systolic BP <70 mmHg), start norepinephrine as an emergency measure while fluid resuscitation continues simultaneously, rather than waiting for complete volume repletion 2, 3
  • Consider early norepinephrine when diastolic blood pressure ≤40 mmHg or diastolic shock index (heart rate/diastolic BP) ≥3, indicating severely depressed arterial tone 3

Norepinephrine Administration Protocol

Starting Dose and Titration

  • Initiate at 0.1-0.5 mcg/kg/min (approximately 7-35 mcg/min in a 70 kg adult or 0.5 mg/h) 1, 2
  • Titrate every 4 hours by 0.5 mg/h increments to maximum 3 mg/h 2
  • Target mean arterial pressure (MAP) of 65 mmHg initially 1, 2

Route of Administration

  • Central venous access is strongly preferred to minimize extravasation risk and tissue necrosis 1, 2
  • If central access is unavailable or delayed, peripheral IV or intraosseous administration can be used temporarily with strict monitoring 2, 4
  • Place arterial catheter as soon as practical for continuous blood pressure monitoring 2

Monitoring Parameters

  • Monitor blood pressure and heart rate every 5-15 minutes during initial titration 1, 2
  • Assess tissue perfusion markers: lactate clearance, urine output >50 mL/h, mental status, capillary refill, skin color 1, 2
  • Titrate to both MAP target AND markers of adequate tissue perfusion, not MAP alone 1, 2

Escalation Strategy for Refractory Hypotension

Second-Line Vasopressor

  • When norepinephrine reaches 0.25 mcg/kg/min and hypotension persists, add vasopressin 0.03-0.04 units/min (do not exceed this dose) 1, 2
  • Vasopressin should be added to norepinephrine to either raise MAP to target or decrease norepinephrine dose, but should not be used as the initial vasopressor 1

Third-Line Options

  • Add epinephrine 0.1-0.5 mcg/kg/min when additional agent is needed to maintain adequate blood pressure 1, 2
  • For persistent hypoperfusion despite adequate vasopressors, add dobutamine up to 20 mcg/kg/min if myocardial dysfunction is present (elevated cardiac filling pressures and low cardiac output) 1, 2

Critical Pitfalls to Avoid

Do NOT Use These as First-Line

  • Dopamine is NOT recommended except in highly selected circumstances (absolute bradycardia with low risk of tachyarrhythmias), as it causes more tachycardia, arrhythmias, and higher mortality compared to norepinephrine 1, 2
  • Phenylephrine should NOT be used as first-line therapy—reserve only for salvage therapy or when norepinephrine causes serious arrhythmias 1, 2
  • Low-dose dopamine has no benefit for renal protection and should not be used 2

Extravasation Management

  • If extravasation occurs, infiltrate phentolamine 5-10 mg diluted in 10-15 mL of saline intradermally at the site immediately to prevent tissue necrosis 1, 2
  • Pediatric dose: 0.1-0.2 mg/kg up to 10 mg 2

Avoid Inadequate Volume Resuscitation

  • Never start norepinephrine in a hypovolemic patient without concurrent fluid resuscitation, as vasoconstriction in hypovolemia causes severe organ hypoperfusion despite "normal" blood pressure 2, 3

Special Clinical Contexts

Timing Considerations

  • Mortality is lowest when vasopressors are delayed by 1 hour and infused from hours 1-6 following onset of shock in patients receiving adequate fluid resuscitation 1
  • However, in profound hypotension with low diastolic pressure, early administration (within first hour) may be beneficial to prevent prolonged hypotension 3

Alternative in Resource-Limited Settings

  • In low- and middle-income countries where norepinephrine availability is limited, adrenaline (epinephrine) infusions are acceptable as the inotrope of choice, given equivalent efficacy to norepinephrine in septic shock 1

Pediatric Dosing

  • Start at 0.1 mcg/kg/min, titrate to desired clinical effect 2
  • Typical range: 0.1-1.0 mcg/kg/min; maximum doses up to 5 mcg/kg/min may be necessary 2

Why Norepinephrine is Superior

  • More efficacious than dopamine for reversing hypotension in septic shock 1
  • Rapidly increases and better stabilizes arterial pressure compared to fluids alone 3
  • Increases mean systemic filling pressure by binding venous adrenergic receptors, transforming unstressed blood volume into stressed blood volume 3
  • May improve end-organ perfusion and reduce fluid overload when started early 3
  • Strong recommendation (1B) with moderate quality evidence from Surviving Sepsis Campaign guidelines 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.